Henrik Alfredéen
Affiliated to Research
E-mail: henrik.alfredeen@ki.se
Visiting address: BioClinicum J5:30, Visionsgatan 4, 17164 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Tran, 171 77 Stockholm
About me
Henrik received his MSc degree in organic chemistry from Stockholm University in 2011. After the degree he started working with radiochemistry at Karolinska Institutet, in Christer Halldin research group, and in 2016 he joined the Radiopharmacy group at Karolinska University Hospital.
In 2023, he started as a PhD student with a focus on developing targeted alpha therapy for high-risk neuroblastoma.
Research
Development of targeted alpha therapies for high-risk neuroblastoma
Articles
- Article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2023;8(1):41